Compared to these approaches, the NLP-EXOSOME COMPLEX STAT3-silencer system offers enhanced stability, improved BBB penetration, and targeted STAT3 inhibition, presenting a promising alternative for GBM therapy. Here, STAT3 is linked to glioblastoma.